
NL - Amsterdam Molecular Therapeutics raises additional EUR 5.67m
Venture-backed Amsterdam Molecular Therapeutics has raised an additional EUR 5.67m from the partial exercise of an over-allotment option. The company had launched an IPO of 5,000,000 new shares on Euronext Amsterdam for an offer price of EUR 10 per share on June 20.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds